SOPHiA DDM™ enables real-time SARS-CoV-2 surveillance, enabling the detection of new and emerging strains with high accuracy and confidence. Furthermore, as vaccination efforts improve around the globe, the use of SOPHiA DDM™ provides access to new insights for better understanding the variants that “escape” immunity. Join us to explore how you can streamline your workflow to achieve higher quality results for SARS-CoV-2 whole-genome analyses.

During this webinar, our experts will:

-Present how the SOPHiA DDM™ platform accelerates SARS-CoV-2 analyses with user-friendly features, such as automatic clade and lineage assignment

-Detail the recent guidelines, established with international partners, for more accurate amplicon-based genotyping of SARS-CoV-2

-Show evidence for a new mutational hotspot, W152

Research Use Only (RUO), Not for Use in Diagnostic Procedures
The information included has been prepared for and is intended for viewing by a global audience. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult local sales representatives.

All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.
Wed, Sep 15, 2021 · 11:00 AM Eastern Time (US & Canada) (GMT -4:00)
Christie Quarles
Senior Clinical Applications Product Manager, SOPHiA GENETICS
Slawomir Kubik
Genomic Research Expert, SOPHiA GENETICS